Since its market release in early 2006, Exubera has faced an uphill battle winning widespread physician and consumer adaption. Now, manufacturer Pfizer has decided to pull the product from its portfolio. From Pfizers third quarter earnings release yesterday:

"[W]e made an important decision regar...




This article is courtesy of dLife Today

Add to Google
Technorati tags: blood presurediabetesglucose monitorinsulinsugar levels

Trackback address for this post

Trackback URL (right click and copy shortcut/link location)

No feedback yet

Leave a comment


Your email address will not be revealed on this site.

Your URL will be displayed.
(Line breaks become <br />)
(Name, email & website)
(Allow users to contact you through a message form (your email will not be revealed.)